IL6 and colitis: In our study, L. sakei CVL-001 administration led to decreased gene expression levels of pro-inflammatory cytokines, such as IL-1β, TNF-α, and IL-6, and increased gene expression levels of anti-inflammatory cytokines, such as IL-10, against DSS-induced colitis (Figure 3).